Truist Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.3M Sell
1,205,777
-1,560,305
-56% -$126M 0.11% 172
2026
Q1
$240M Buy
2,766,082
+257,944
+10% +$24.7M 0.32% 68
2025
Q4
$241M Buy
2,508,138
+98,223
+4% +$9.54M 0.32% 61
2025
Q3
$230M Buy
2,409,915
+168,439
+8% +$15.5M 0.31% 65
2025
Q2
$195M Buy
2,241,476
+116,469
+5% +$9.88M 0.29% 68
2025
Q1
$191M Buy
2,125,007
+968,637
+84% +$86.7M 0.31% 65
2024
Q4
$92.4M Buy
1,156,370
+312,873
+37% +$27.1M 0.14% 135
2024
Q3
$75.9M Sell
843,497
-92,210
-10% -$7.76M 0.12% 168
2024
Q2
$73.6M Sell
935,707
-27,575
-3% -$2.26M 0.11% 181
2024
Q1
$84M Sell
963,282
-29,343
-3% -$2.5M 0.13% 159
2023
Q4
$81.8M Sell
992,625
-196,858
-17% -$15M 0.13% 154
2023
Q3
$93.2M Buy
1,189,483
+87,110
+8% +$7.29M 0.16% 136
2023
Q2
$97.1M Sell
1,102,373
-41,182
-4% -$3.55M 0.16% 133
2023
Q1
$92.2M Sell
1,143,555
-934,582
-45% -$76.2M 0.16% 131
2022
Q4
$162M Sell
2,078,137
-591,633
-22% -$48M 0.28% 86
2022
Q3
$216M Buy
2,669,770
+258,936
+11% +$23.3M 0.41% 57
2022
Q2
$216M Buy
2,410,834
+114,688
+5% +$11.6M 0.4% 59
2022
Q1
$255M Buy
2,296,146
+149,061
+7% +$15.7M 0.4% 57
2021
Q4
$222M Buy
2,147,085
+28,863
+1% +$3.34M 0.34% 73
2021
Q3
$266M Sell
2,118,222
-18,401
-0.9% -$2.38M 0.44% 53
2021
Q2
$265M Sell
2,136,623
-53,925
-2% -$6.77M 0.43% 54
2021
Q1
$259M Buy
2,190,548
+224,578
+11% +$26.3M 0.45% 52
2020
Q4
$230M Buy
1,965,970
+70,400
+4% +$7.75M 0.44% 51
2020
Q3
$197M Sell
1,895,570
-101,234
-5% -$10.2M 0.43% 51
2020
Q2
$183M Buy
1,996,804
+28,826
+1% +$2.76M 0.41% 56
2020
Q1
$177M Buy
1,967,978
+3,946
+0.2% +$420K 0.47% 51
2019
Q4
$223M Buy
1,964,032
+1,743,363
+790% +$191M 0.45% 48
2019
Q3
$24M Buy
220,669
+4,097
+2% +$427K 0.41% 58
2019
Q2
$21.1M Buy
216,572
+949
+0.4% +$86.6K 0.37% 67
2019
Q1
$19.6M Buy
215,623
+18,848
+10% +$1.69M 0.35% 74
2018
Q4
$17.9M Buy
196,775
+11,345
+6% +$1.06M 0.37% 68
2018
Q3
$18.2M Buy
185,430
+5,208
+3% +$481K 0.33% 77
2018
Q2
$15.4M Buy
180,222
+9,089
+5% +$759K 0.29% 91
2018
Q1
$13.7M Buy
171,133
+34,229
+25% +$2.82M 0.26% 100
2017
Q4
$11.1M Buy
136,904
+64,128
+88% +$5.14M 0.21% 127
2017
Q3
$5.66M Buy
72,776
+3,365
+5% +$279K 0.11% 223
2017
Q2
$6.16M Buy
69,411
+4,191
+6% +$353K 0.12% 208
2017
Q1
$5.25M Buy
65,220
+18,419
+39% +$1.44M 0.11% 227
2016
Q4
$3.33M Buy
46,801
+930
+2% +$73.1K 0.07% 294
2016
Q3
$3.96M Buy
45,871
+762
+2% +$66.4K 0.08% 260
2016
Q2
$3.91M Buy
45,109
+1,319
+3% +$107K 0.08% 268
2016
Q1
$3.28M Sell
43,790
-1,989
-4% -$150K 0.08% 253
2015
Q4
$3.52M Sell
45,779
-5,023
-10% -$378K 0.09% 239
2015
Q3
$3.4M Sell
50,802
-2,683
-5% -$198K 0.09% 247
2015
Q2
$3.96M Sell
53,485
-4,297
-7% -$328K 0.11% 212
2015
Q1
$4.51M Buy
57,782
+12,574
+28% +$953K 0.13% 188
2014
Q4
$3.26M Buy
45,208
+2,036
+5% +$141K 0.1% 216
2014
Q3
$2.67M Sell
43,172
-512
-1% -$32.6K 0.08% 237
2014
Q2
$2.79M Buy
43,684
+1,039
+2% +$63.1K 0.08% 242
2014
Q1
$2.62M Sell
42,645
-2,371
-5% -$138K 0.08% 239
2013
Q4
$2.58M Sell
45,016
-1,587
-3% -$90K 0.08% 245
2013
Q3
$2.48M Sell
46,603
-2,748
-6% -$148K 0.09% 237
2013
Q2
$2.54M Buy
+49,351
New +$2.44M 0.09% 224

Other funds holding MDT

Truist Financial's MDT Position: Q2 2026 in Review

Truist Financial reduced its Medtronic (MDT) stake by 56% in Q2 2026, selling an estimated $126M and leaving 1,205,777 shares worth $94.3M. The position accounts for 0.11% of the portfolio, ranked #172.

Truist Financial first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $266M in Q3 2021. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Truist Financial held 1,205,777 shares of Medtronic worth $94.3M as of Q2 2026.
  • Truist Financial sold 1,560,305 Medtronic shares in Q2 2026, an estimated $126M.
  • Medtronic made up 0.11% of Truist Financial's portfolio in Q2 2026, its #172 holding.
  • Truist Financial first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Truist Financial's Medtronic position peaked at $266M in Q3 2021.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.